The global market for CRISPR Gene Editing Therapy was valued at US$ 476 million in the year 2024 and is projected to reach a revised size of US$ 662 million by 2031, growing at a CAGR of 5.4% during the forecast period.

CRISPR Gene Editing Therapy Market

CRISPR Gene Editing Therapy is a treatment method that utilizes the CRISPR-Cas9 system for precise gene editing. The CRISPR-Cas9 system, derived from bacteria and archaea, is an immune system that recognizes and cuts specific DNA sequences. In gene editing therapy, scientists leverage this property of the CRISPR-Cas9 system by designing specific RNA molecules to guide the Cas9 enzyme to cut the DNA sequence of the target gene, enabling the addition, deletion, or replacement of genes. This therapy holds great potential in treating genetic diseases, cancer, infectious diseases, and more. By directly correcting the disease-causing genes, CRISPR Gene Editing Therapy has the potential to provide radical treatments for patients, improving or even curing these diseases.

North American market for CRISPR Gene Editing Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for CRISPR Gene Editing Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for CRISPR Gene Editing Therapy in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of CRISPR Gene Editing Therapy include Intellia Therapeutics, BRL Medicine, Edigene, Bdgene, Chigenovo, Reforgene Medicine, Verve Therapeutics, Beam Therapeutics, CRISPR Therapeutics, Branca Bunús, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for CRISPR Gene Editing Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR Gene Editing Therapy.

The CRISPR Gene Editing Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CRISPR Gene Editing Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the CRISPR Gene Editing Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of CRISPR Gene Editing Therapy Market Report

Report Metric	Details
Report Name	CRISPR Gene Editing Therapy Market
Accounted market size in year	US$ 476 million
Forecasted market size in 2031	US$ 662 million
CAGR	5.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	External Use Preparations Injection Others
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Intellia Therapeutics, BRL Medicine, Edigene, Bdgene, Chigenovo, Reforgene Medicine, Verve Therapeutics, Beam Therapeutics, CRISPR Therapeutics, Branca Bunús, Excision BioTherapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRISPR Gene Editing Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is CRISPR Gene Editing Therapy Market growing?

Ans: The CRISPR Gene Editing Therapy Market witnessing a CAGR of 5.4% during the forecast period 2025-2031.

What is the CRISPR Gene Editing Therapy Market size in 2031?

Ans: The CRISPR Gene Editing Therapy Market size in 2031 will be US$ 662 million.

Who are the main players in the CRISPR Gene Editing Therapy Market report?

Ans: The main players in the CRISPR Gene Editing Therapy Market are Intellia Therapeutics, BRL Medicine, Edigene, Bdgene, Chigenovo, Reforgene Medicine, Verve Therapeutics, Beam Therapeutics, CRISPR Therapeutics, Branca Bunús, Excision BioTherapeutics

What are the Application segmentation covered in the CRISPR Gene Editing Therapy Market report?

Ans: The Applications covered in the CRISPR Gene Editing Therapy Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the CRISPR Gene Editing Therapy Market report?

Ans: The Types covered in the CRISPR Gene Editing Therapy Market report are External Use Preparations, Injection, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global CRISPR Gene Editing Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 External Use Preparations

1.2.3 Injection

1.2.4 Others

1.3 Market by Application

1.3.1 Global CRISPR Gene Editing Therapy Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global CRISPR Gene Editing Therapy Market Perspective (2020-2031)

2.2 Global CRISPR Gene Editing Therapy Growth Trends by Region

2.2.1 Global CRISPR Gene Editing Therapy Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 CRISPR Gene Editing Therapy Historic Market Size by Region (2020-2025)

2.2.3 CRISPR Gene Editing Therapy Forecasted Market Size by Region (2026-2031)

2.3 CRISPR Gene Editing Therapy Market Dynamics

2.3.1 CRISPR Gene Editing Therapy Industry Trends

2.3.2 CRISPR Gene Editing Therapy Market Drivers

2.3.3 CRISPR Gene Editing Therapy Market Challenges

2.3.4 CRISPR Gene Editing Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top CRISPR Gene Editing Therapy Players by Revenue

3.1.1 Global Top CRISPR Gene Editing Therapy Players by Revenue (2020-2025)

3.1.2 Global CRISPR Gene Editing Therapy Revenue Market Share by Players (2020-2025)

3.2 Global Top CRISPR Gene Editing Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by CRISPR Gene Editing Therapy Revenue

3.4 Global CRISPR Gene Editing Therapy Market Concentration Ratio

3.4.1 Global CRISPR Gene Editing Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by CRISPR Gene Editing Therapy Revenue in 2024

3.5 Global Key Players of CRISPR Gene Editing Therapy Head office and Area Served

3.6 Global Key Players of CRISPR Gene Editing Therapy, Product and Application

3.7 Global Key Players of CRISPR Gene Editing Therapy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 CRISPR Gene Editing Therapy Breakdown Data by Type

4.1 Global CRISPR Gene Editing Therapy Historic Market Size by Type (2020-2025)

4.2 Global CRISPR Gene Editing Therapy Forecasted Market Size by Type (2026-2031)

5 CRISPR Gene Editing Therapy Breakdown Data by Application

5.1 Global CRISPR Gene Editing Therapy Historic Market Size by Application (2020-2025)

5.2 Global CRISPR Gene Editing Therapy Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America CRISPR Gene Editing Therapy Market Size (2020-2031)

6.2 North America CRISPR Gene Editing Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America CRISPR Gene Editing Therapy Market Size by Country (2020-2025)

6.4 North America CRISPR Gene Editing Therapy Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe CRISPR Gene Editing Therapy Market Size (2020-2031)

7.2 Europe CRISPR Gene Editing Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe CRISPR Gene Editing Therapy Market Size by Country (2020-2025)

7.4 Europe CRISPR Gene Editing Therapy Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific CRISPR Gene Editing Therapy Market Size (2020-2031)

8.2 Asia-Pacific CRISPR Gene Editing Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific CRISPR Gene Editing Therapy Market Size by Region (2020-2025)

8.4 Asia-Pacific CRISPR Gene Editing Therapy Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America CRISPR Gene Editing Therapy Market Size (2020-2031)

9.2 Latin America CRISPR Gene Editing Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America CRISPR Gene Editing Therapy Market Size by Country (2020-2025)

9.4 Latin America CRISPR Gene Editing Therapy Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa CRISPR Gene Editing Therapy Market Size (2020-2031)

10.2 Middle East & Africa CRISPR Gene Editing Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa CRISPR Gene Editing Therapy Market Size by Country (2020-2025)

10.4 Middle East & Africa CRISPR Gene Editing Therapy Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Intellia Therapeutics

11.1.1 Intellia Therapeutics Company Details

11.1.2 Intellia Therapeutics Business Overview

11.1.3 Intellia Therapeutics CRISPR Gene Editing Therapy Introduction

11.1.4 Intellia Therapeutics Revenue in CRISPR Gene Editing Therapy Business (2020-2025)

11.1.5 Intellia Therapeutics Recent Development

11.2 BRL Medicine

11.2.1 BRL Medicine Company Details

11.2.2 BRL Medicine Business Overview

11.2.3 BRL Medicine CRISPR Gene Editing Therapy Introduction

11.2.4 BRL Medicine Revenue in CRISPR Gene Editing Therapy Business (2020-2025)

11.2.5 BRL Medicine Recent Development

11.3 Edigene

11.3.1 Edigene Company Details

11.3.2 Edigene Business Overview

11.3.3 Edigene CRISPR Gene Editing Therapy Introduction

11.3.4 Edigene Revenue in CRISPR Gene Editing Therapy Business (2020-2025)

11.3.5 Edigene Recent Development

11.4 Bdgene

11.4.1 Bdgene Company Details

11.4.2 Bdgene Business Overview

11.4.3 Bdgene CRISPR Gene Editing Therapy Introduction

11.4.4 Bdgene Revenue in CRISPR Gene Editing Therapy Business (2020-2025)

11.4.5 Bdgene Recent Development

11.5 Chigenovo

11.5.1 Chigenovo Company Details

11.5.2 Chigenovo Business Overview

11.5.3 Chigenovo CRISPR Gene Editing Therapy Introduction

11.5.4 Chigenovo Revenue in CRISPR Gene Editing Therapy Business (2020-2025)

11.5.5 Chigenovo Recent Development

11.6 Reforgene Medicine

11.6.1 Reforgene Medicine Company Details

11.6.2 Reforgene Medicine Business Overview

11.6.3 Reforgene Medicine CRISPR Gene Editing Therapy Introduction

11.6.4 Reforgene Medicine Revenue in CRISPR Gene Editing Therapy Business (2020-2025)

11.6.5 Reforgene Medicine Recent Development

11.7 Verve Therapeutics

11.7.1 Verve Therapeutics Company Details

11.7.2 Verve Therapeutics Business Overview

11.7.3 Verve Therapeutics CRISPR Gene Editing Therapy Introduction

11.7.4 Verve Therapeutics Revenue in CRISPR Gene Editing Therapy Business (2020-2025)

11.7.5 Verve Therapeutics Recent Development

11.8 Beam Therapeutics

11.8.1 Beam Therapeutics Company Details

11.8.2 Beam Therapeutics Business Overview

11.8.3 Beam Therapeutics CRISPR Gene Editing Therapy Introduction

11.8.4 Beam Therapeutics Revenue in CRISPR Gene Editing Therapy Business (2020-2025)

11.8.5 Beam Therapeutics Recent Development

11.9 CRISPR Therapeutics

11.9.1 CRISPR Therapeutics Company Details

11.9.2 CRISPR Therapeutics Business Overview

11.9.3 CRISPR Therapeutics CRISPR Gene Editing Therapy Introduction

11.9.4 CRISPR Therapeutics Revenue in CRISPR Gene Editing Therapy Business (2020-2025)

11.9.5 CRISPR Therapeutics Recent Development

11.10 Branca Bunús

11.10.1 Branca Bunús Company Details

11.10.2 Branca Bunús Business Overview

11.10.3 Branca Bunús CRISPR Gene Editing Therapy Introduction

11.10.4 Branca Bunús Revenue in CRISPR Gene Editing Therapy Business (2020-2025)

11.10.5 Branca Bunús Recent Development

11.11 Excision BioTherapeutics

11.11.1 Excision BioTherapeutics Company Details

11.11.2 Excision BioTherapeutics Business Overview

11.11.3 Excision BioTherapeutics CRISPR Gene Editing Therapy Introduction

11.11.4 Excision BioTherapeutics Revenue in CRISPR Gene Editing Therapy Business (2020-2025)

11.11.5 Excision BioTherapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Intellia Therapeutics

Excision BioTherapeutics

List of Tables

Table 1. Global CRISPR Gene Editing Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of External Use Preparations

Table 3. Key Players of Injection

Table 4. Key Players of Others

Table 5. Global CRISPR Gene Editing Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global CRISPR Gene Editing Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global CRISPR Gene Editing Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global CRISPR Gene Editing Therapy Market Share by Region (2020-2025)

Table 9. Global CRISPR Gene Editing Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global CRISPR Gene Editing Therapy Market Share by Region (2026-2031)

Table 11. CRISPR Gene Editing Therapy Market Trends

Table 12. CRISPR Gene Editing Therapy Market Drivers

Table 13. CRISPR Gene Editing Therapy Market Challenges

Table 14. CRISPR Gene Editing Therapy Market Restraints

Table 15. Global CRISPR Gene Editing Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global CRISPR Gene Editing Therapy Market Share by Players (2020-2025)

Table 17. Global Top CRISPR Gene Editing Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR Gene Editing Therapy as of 2024)

Table 18. Ranking of Global Top CRISPR Gene Editing Therapy Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by CRISPR Gene Editing Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of CRISPR Gene Editing Therapy, Headquarters and Area Served

Table 21. Global Key Players of CRISPR Gene Editing Therapy, Product and Application

Table 22. Global Key Players of CRISPR Gene Editing Therapy, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global CRISPR Gene Editing Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global CRISPR Gene Editing Therapy Revenue Market Share by Type (2020-2025)

Table 26. Global CRISPR Gene Editing Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global CRISPR Gene Editing Therapy Revenue Market Share by Type (2026-2031)

Table 28. Global CRISPR Gene Editing Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global CRISPR Gene Editing Therapy Revenue Market Share by Application (2020-2025)

Table 30. Global CRISPR Gene Editing Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global CRISPR Gene Editing Therapy Revenue Market Share by Application (2026-2031)

Table 32. North America CRISPR Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America CRISPR Gene Editing Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America CRISPR Gene Editing Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe CRISPR Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe CRISPR Gene Editing Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe CRISPR Gene Editing Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific CRISPR Gene Editing Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific CRISPR Gene Editing Therapy Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific CRISPR Gene Editing Therapy Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America CRISPR Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America CRISPR Gene Editing Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America CRISPR Gene Editing Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa CRISPR Gene Editing Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa CRISPR Gene Editing Therapy Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa CRISPR Gene Editing Therapy Market Size by Country (2026-2031) & (US$ Million)

Table 47. Intellia Therapeutics Company Details

Table 48. Intellia Therapeutics Business Overview

Table 49. Intellia Therapeutics CRISPR Gene Editing Therapy Product

Table 50. Intellia Therapeutics Revenue in CRISPR Gene Editing Therapy Business (2020-2025) & (US$ Million)

Table 51. Intellia Therapeutics Recent Development

Table 52. BRL Medicine Company Details

Table 53. BRL Medicine Business Overview

Table 54. BRL Medicine CRISPR Gene Editing Therapy Product

Table 55. BRL Medicine Revenue in CRISPR Gene Editing Therapy Business (2020-2025) & (US$ Million)

Table 56. BRL Medicine Recent Development

Table 57. Edigene Company Details

Table 58. Edigene Business Overview

Table 59. Edigene CRISPR Gene Editing Therapy Product

Table 60. Edigene Revenue in CRISPR Gene Editing Therapy Business (2020-2025) & (US$ Million)

Table 61. Edigene Recent Development

Table 62. Bdgene Company Details

Table 63. Bdgene Business Overview

Table 64. Bdgene CRISPR Gene Editing Therapy Product

Table 65. Bdgene Revenue in CRISPR Gene Editing Therapy Business (2020-2025) & (US$ Million)

Table 66. Bdgene Recent Development

Table 67. Chigenovo Company Details

Table 68. Chigenovo Business Overview

Table 69. Chigenovo CRISPR Gene Editing Therapy Product

Table 70. Chigenovo Revenue in CRISPR Gene Editing Therapy Business (2020-2025) & (US$ Million)

Table 71. Chigenovo Recent Development

Table 72. Reforgene Medicine Company Details

Table 73. Reforgene Medicine Business Overview

Table 74. Reforgene Medicine CRISPR Gene Editing Therapy Product

Table 75. Reforgene Medicine Revenue in CRISPR Gene Editing Therapy Business (2020-2025) & (US$ Million)

Table 76. Reforgene Medicine Recent Development

Table 77. Verve Therapeutics Company Details

Table 78. Verve Therapeutics Business Overview

Table 79. Verve Therapeutics CRISPR Gene Editing Therapy Product

Table 80. Verve Therapeutics Revenue in CRISPR Gene Editing Therapy Business (2020-2025) & (US$ Million)

Table 81. Verve Therapeutics Recent Development

Table 82. Beam Therapeutics Company Details

Table 83. Beam Therapeutics Business Overview

Table 84. Beam Therapeutics CRISPR Gene Editing Therapy Product

Table 85. Beam Therapeutics Revenue in CRISPR Gene Editing Therapy Business (2020-2025) & (US$ Million)

Table 86. Beam Therapeutics Recent Development

Table 87. CRISPR Therapeutics Company Details

Table 88. CRISPR Therapeutics Business Overview

Table 89. CRISPR Therapeutics CRISPR Gene Editing Therapy Product

Table 90. CRISPR Therapeutics Revenue in CRISPR Gene Editing Therapy Business (2020-2025) & (US$ Million)

Table 91. CRISPR Therapeutics Recent Development

Table 92. Branca Bunús Company Details

Table 93. Branca Bunús Business Overview

Table 94. Branca Bunús CRISPR Gene Editing Therapy Product

Table 95. Branca Bunús Revenue in CRISPR Gene Editing Therapy Business (2020-2025) & (US$ Million)

Table 96. Branca Bunús Recent Development

Table 97. Excision BioTherapeutics Company Details

Table 98. Excision BioTherapeutics Business Overview

Table 99. Excision BioTherapeutics CRISPR Gene Editing Therapy Product

Table 100. Excision BioTherapeutics Revenue in CRISPR Gene Editing Therapy Business (2020-2025) & (US$ Million)

Table 101. Excision BioTherapeutics Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

Table 105. Authors List of This Report

List of Figures

Figure 1. CRISPR Gene Editing Therapy Picture

Figure 2. Global CRISPR Gene Editing Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global CRISPR Gene Editing Therapy Market Share by Type: 2024 VS 2031

Figure 4. External Use Preparations Features

Figure 5. Injection Features

Figure 6. Others Features

Figure 7. Global CRISPR Gene Editing Therapy Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global CRISPR Gene Editing Therapy Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Others Case Studies

Figure 12. CRISPR Gene Editing Therapy Report Years Considered

Figure 13. Global CRISPR Gene Editing Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global CRISPR Gene Editing Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global CRISPR Gene Editing Therapy Market Share by Region: 2024 VS 2031

Figure 16. Global CRISPR Gene Editing Therapy Market Share by Players in 2024

Figure 17. Global CRISPR Gene Editing Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by CRISPR Gene Editing Therapy Revenue in 2024

Figure 19. North America CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America CRISPR Gene Editing Therapy Market Share by Country (2020-2031)

Figure 21. United States CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe CRISPR Gene Editing Therapy Market Share by Country (2020-2031)

Figure 25. Germany CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific CRISPR Gene Editing Therapy Market Share by Region (2020-2031)

Figure 33. China CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America CRISPR Gene Editing Therapy Market Share by Country (2020-2031)

Figure 41. Mexico CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa CRISPR Gene Editing Therapy Market Share by Country (2020-2031)

Figure 45. Turkey CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE CRISPR Gene Editing Therapy Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Intellia Therapeutics Revenue Growth Rate in CRISPR Gene Editing Therapy Business (2020-2025)

Figure 49. BRL Medicine Revenue Growth Rate in CRISPR Gene Editing Therapy Business (2020-2025)

Figure 50. Edigene Revenue Growth Rate in CRISPR Gene Editing Therapy Business (2020-2025)

Figure 51. Bdgene Revenue Growth Rate in CRISPR Gene Editing Therapy Business (2020-2025)

Figure 52. Chigenovo Revenue Growth Rate in CRISPR Gene Editing Therapy Business (2020-2025)

Figure 53. Reforgene Medicine Revenue Growth Rate in CRISPR Gene Editing Therapy Business (2020-2025)

Figure 54. Verve Therapeutics Revenue Growth Rate in CRISPR Gene Editing Therapy Business (2020-2025)

Figure 55. Beam Therapeutics Revenue Growth Rate in CRISPR Gene Editing Therapy Business (2020-2025)

Figure 56. CRISPR Therapeutics Revenue Growth Rate in CRISPR Gene Editing Therapy Business (2020-2025)

Figure 57. Branca Bunús Revenue Growth Rate in CRISPR Gene Editing Therapy Business (2020-2025)

Figure 58. Excision BioTherapeutics Revenue Growth Rate in CRISPR Gene Editing Therapy Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global CRISPR Gene Editing Market Research Report 2024

Global CRISPR Kit Market Research Report 2024

Global CRISPR associated Nucleases Market Research Report 2024

Global Gene Editing Drug Market Research Report 2024

Global CRISPR Based Therapeutics Market Research Report 2024

Global CRISPR Genome Editing Market Insights Forecast to 2030

Global Gene Editing Technology Market Research Report 2024

Global Gene Editing Technologies Market Insights Forecast to 2030

Global Microbial Gene Editing Service Market Research Report 2024

Prime Editing Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Plant Breeding and CRISPR Plants Market Insights Forecast to 2030

Global Gene Editing Service Market Insights Forecast to 2030

Global Gene Editing Tools Market Insights Forecast to 2030

Global CRISPR Cas9 Gene Editing Service Market Research Report 2025

Global CRISPR Cas Genes Market Research Report 2024

Global Subsea Production and Processing Systems Market Insights Forecast to 2030

Global Delivery System for Gene Therapy Market Research Report 2025

CRISPR in Agriculture Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CRISPR Editing Platform Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions